insights_auto
Why is 0QF up ၁၂.၈၅%?
Dive Deeperchevron_right
0QF:FRA
Moderna Inc
၁၉၇.၅၄ €
arrow_upward
+၁၂.၈၅%(+၂၂.၅၀) 1D
အောက် ၉, GMT+၂ ၂၂:၀၀:၀၀ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
၁၇၄.၆၀ €
High
၂၀၀.၀၀ €
Low
၁၇၄.၄၈ €
Mkt. cap
ဋေ ၈.၉၈ ထ
Avg. vol.
၁.၅၀ ထောင်
Volume
၀.၀၀
52-wk high
၂၀၀.၀၀ €
52-wk low
၁၉.၂၆ €
No. of employees
၅ ထောင်
Open
၁၇၄.၆၀ €
High
၂၀၀.၀၀ €
Low
၁၇၄.၄၈ €
Mkt. cap
ဋေ ၈.၉၈ ထ
Avg. vol.
၁.၅၀ ထောင်
Volume
၀.၀၀
52-wk high
၂၀၀.၀၀ €
52-wk low
၁၉.၂၆ €
No. of employees
၅ ထောင်
News stories
From web sources and news partners
JournalArta
·
ပြီးခဲ့သည့် ၆ နာရီ
Covid vaccine stock S&P leader surges: What to Know
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၃ နာရီ
Moderna Stock Surge Puts These Oncology Biotechs On Retail Investors Radar
The Motley Fool
·
ပြီးခဲ့သည့် ၂၃ နာရီ
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell?
The Globe and Mail
·
ပြီးခဲ့သည့် ၂ ရက်
This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc